Skip to main content

A worldwide technology outage is causing disruption to some State of Illinois online systems. We are aware of this issue and are diligently working on restoration.

Notice of Privacy Incident
We are offering two in-person Healthchoice Illinois Listening Sessions allow you the opportunity to talk about your experiences with HealthChoice Illinois managed care. Please be sure to register for one of these important events.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: June 15, 2016

Drug Name	Review Type	Class	Manufacturer
Dyanavel XR Susp.	New Drug Initial Review	Stimulants	Tris Pharma, Inc.
Viberzi	New Drug Initial Review	Irritable Bowel with diarrhea	Allergan
Xeljanz	New Drug Appeal	Rheumatoid Arthritis	Pfizer
Xeljanz XR	New Drug Appeal	Rheumatoid Arthritis	Pfizer
Savaysa	New Drug Appeal	NOAC Anti-Coagulant	Daiichi Sankyo
Orenitram	New Drug Appeal	Pulmonary Arterial Hypertension	United Therapeutics
Brilinta	PDL Appeal	Platelet Aggregation Inhibitor	AstraZeneca